A groundbreaking study published in PLOS Digital Health unveils novel insights into menstrual pain and period poverty by analyzing supermarket loyalty card data, shining a spotlight on socioeconomic disparities in menstrual pain relief across England. Led by Dr. Victoria Sivill from the University of Bristol, this research utilized transactional logs from a prominent UK health and beauty retailer to reveal compelling trends affecting millions of individuals from 2006 to 2015. By evaluating purchasing behaviors on an unprecedented scale, the study bridges a vital gap in public health understanding and policy formulation regarding menstrual pain management.
Menstrual pain, known medically as dysmenorrhea, affects a significant proportion of menstruating individuals worldwide and has long been acknowledged as a factor negatively impacting day-to-day life, including reduced participation in educational and occupational settings. Despite its prevalence, menstrual pain remains vastly understudied in large population datasets due to limitations in traditional research methods. The innovative approach by Sivill and colleagues circumvents these challenges by leveraging consumer behavior data, offering a powerful proxy for real-world health concerns and treatment access patterns.
The research team amassed an anonymized dataset totaling 211 million transactions made by approximately 3.4 million customers over nearly a decade. This enormous dataset allowed the researchers to track concurrent purchases of menstrual products and over-the-counter pain relief medications, thereby identifying patterns indicative of menstrual pain management. The methodology entailed measuring the frequency and co-occurrence of these product purchases, alongside baseline rates of pain relief purchases to isolate specific behaviors linked to menstrual pain episodes.
Intriguingly, the study found that just over one in four women (26.7%) who purchased menstrual products simultaneously bought pain relief, suggesting a significant proportion actively seeks over-the-counter solutions during their menstrual cycle. Moreover, this group was nearly four times more likely to purchase pain relief products during these transactions compared to their regular shopping habits, lending robust validation to the assumption that these purchases accurately reflect menstrual pain experiences.
Another notable confirmation of their methodology came from the regularity of menstrual product purchases. The most common interval observed between consecutive menstrual product buys was precisely 28 days, which aligns closely with the average menstrual cycle length. This strongly indicates that the shopping data captures genuine cyclical health behaviors rather than random purchasing and solidifies the utility of consumer transaction logs as a novel epidemiological tool.
A critical finding of this study revolves around the socioeconomic gradient in purchasing behavior. Customers residing in the lowest-income regions of England were found to be 32% less likely to purchase pain relief at the same time as menstrual products compared to individuals in higher-income areas. This disparity likely reflects the financial barriers faced in acquiring over-the-counter medications rather than true differences in the prevalence or severity of menstrual pain—underscoring pressing inequities in access to menstrual health management resources.
Dr. Sivill and her colleagues emphasize that these findings illuminate the intertwined issues of menstrual pain prevalence and period poverty, which refers broadly to the lack of access to sanitary products and related health commodities. Such socioeconomic dimensions exacerbate health disparities and demand targeted public health interventions that address affordability and availability of essential menstrual pain relief within deprived communities.
This study represents a compelling example of how ‘big data’ derived from everyday consumer activities can be harnessed to uncover hidden health dynamics that traditional surveys and clinical studies might miss. It invites a reevaluation of how menstrual health is examined at the population level and urges policymakers to integrate menstrual pain relief into broader frameworks of health equity initiatives.
Co-author Dr. James Goulding highlights the transformational potential of these insights, remarking on how emerging data science methodologies are invaluable in surfacing health issues that have historically been sidelined. Menstrual pain, despite its ubiquity, has received insufficient scientific attention and resource allocation, and findings like these pave the way for improved recognition and support.
Another co-author, Dr. Anya Skatova, reflects on the striking clarity with which shopping data illuminates the widespread necessity for menstrual painkillers, making visible a previously intangible public health challenge. This evidence base can serve as a catalyst for systemic change by promoting menstrual pain as a tangible health priority requiring dedicated treatment protocols and resource distribution.
Furthermore, the study’s methodological framework opens avenues for future research across health domains where direct epidemiological data are scarce. By leveraging transactional data from consumer purchasing environments, researchers gain access to rich behavioral signals reflecting health status, medication usage, and potentially unmet needs. Such approaches can complement clinical data, improving accuracy in monitoring health trends and inequities at a granular level.
The implications of the study extend beyond academic interest, pressing for practical responses. Public health campaigns must increase awareness of menstrual pain as a significant health burden, and policymakers should consider subsidizing pain relief medications alongside menstrual products, particularly in low-income regions. Tackling the financial barriers restricting access to these essential goods is crucial for reducing the broader societal costs linked to untreated menstrual pain.
This research, funded by the Alan Turing Institute and the UKRI Future Leaders Fellowship, stands out for its innovative use of observational data and commitment to addressing overlooked health disparities. The open-access publication invites a wide audience ranging from healthcare professionals to policymakers and advocates to engage with this urgently needed conversation about menstrual health equity.
In conclusion, the study by Sivill et al. effectively demonstrates how detailed transaction data can illuminate real-world health behaviors, revealing significant socioeconomic disparities in menstrual pain relief access within England. It prompts a reevaluation of menstrual pain’s social and economic dimensions and provides a compelling foundation for targeted interventions designed to improve health outcomes and equity for menstruating individuals everywhere.
Subject of Research: People
Article Title: What can shopping transactional data reveal about relative prevalence of menstrual pain and period poverty in England?
News Publication Date: 28-May-2026
Web References:
https://doi.org/10.1371/journal.pdig.0001308
References:
Sivill V, Ljevar V, Goulding J, Skatova A (2026) What can shopping transactional data reveal about relative prevalence of menstrual pain and period poverty in England? PLOS Digit Health 5(5): e0001308
Image Credits:
Credit: Sivill et al, PLOS Digital Health, 2026
Keywords:
Menstrual pain, dysmenorrhea, period poverty, socioeconomic disparities, menstrual health, over-the-counter medication, transactional data, big data epidemiology, health equity, public health intervention, observational study, United Kingdom
